CVS is now covering long-acting injectable PrEP, representing a shift from last year when the pharmacy giant announced it was ...

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden administration announced October 21. The news comes just weeks after it was announced ...

Kenya will this year begin rolling out a new long-acting injectable HIV prevention drug, Lenacapavir, positioning the country ...

Australia's taken another step in HIV prevention, with the TGA approving long-acting drug lenacapavir—but access is vital, ...

After Thailand, Cambodia becomes the second Asian country to rollout long-acting and injectable options to protect oneself from getting infected with HIV. United Nations health agency (formally known ...

Injectable PrEP is coming to the UK, as the National Institute for Health and Care Excellence (NICE) has approved cabotegravir (Apretude) – a groundbreaking development against HIV/AIDS. The rollout ...

The Biden-Harris administration announced Monday a new requirement for insurance providers to cover injectable PrEP in their policies without a co-payment for consumers. The new rule, built on ...

The Biden administration on Oct. 21 issued a new proposed rule that would require health insurance providers to cover an injectable form of the HIV prevention medication known as PrEP, marking a ...

HOUSTON — The fight against HIV has come a long way, and new advancements in prevention are changing the game. One of the latest breakthroughs is a long-lasting injectable form of PrEP (pre-exposure ...

Lenacapavir, a long-acting injectable PrEP, requires two injections annually, marking a significant advancement in HIV ...

Add Yahoo as a preferred source to see more of our stories on Google. Northern Ireland has approved the use of injectable PrEP (Image: Pexels) The new long lasting drug, cabotegravir, is administered ...